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Background: Colorectal cancer (CRC) is the most frequently diagnosed cancer in Spain.
Socioeconomic inequalities in cancer survival are not documented in Spain. We aim to study
the association of socioeconomic inequalities with overall mortality and survival among
CRC patients in southern Spain.
Methods: We conducted a multilevel population-based cohort study, including CRC cases
for the period 2011–2013. The study time-to-event outcome was death, and the primary
exposure was CRC patients’ socioeconomic status assessed by the Spanish deprivation index
at the census tract level. We used a mixed-effects flexible hazard model, including census
tract as a random intercept, to derive overall survival estimates by deprivation.
Results: Among 3589 CRC patients and 12,148 person-years at risk (pyr), 964 patients died
before the end of the follow-up. Mortality by deprivation showed the highest mortality rate
for the most deprived group (96.2 per 1000 pyr, 95% CI: 84.0–110.2). After adjusting for
sex, age, cancer stage, and the area of residence, the most deprived had a 60% higher excess
mortality risk than the less deprived group (excess mortality risk ratio: 1.6, 95% CI: 1.1–2.3).
Conclusions: We found a consistent association between deprivation and CRC excess
mortality and survival. The reasons behind these inequalities need further investigation in
order to improve equality cancer outcomes in all social groups.
Keywords: socioeconomic inequalities, colorectal cancer, survival, population-based
epidemiology, epidemiological methods, multilevel
Introduction
In 2018, there were 9.6 million deaths caused by cancer worldwide, with cancer
being the second leading cause of death.1 Mainly due to global aging, the incidence
of cancer is expected to increase in the coming decades in Europe. The economic
and societal costs of cancer are rising sharply, affecting the economic growth of
western countries.2 Population-based cancer registries are an essential public health
resource for epidemiological surveillance and cancer control.3 Cancer registries
provide population-based cancer survival estimates as a general indicator of the
natural history of the disease and the effectiveness of the health system.4 In north-
ern European countries, cancer registries have a long tradition of using indices of
deprivation to characterize cancer socioeconomic inequalities at a geographical
level.5
Socioeconomic inequalities in cancer survival are well documented worldwide.6–10
In the United Kingdom, cancer patients living in wealthier areas have higher survival
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than those living in more disadvantaged areas.11 However, in
Spain, there are no documented socioeconomic inequalities
in cancer survival.
Recently, a deprivation index was developed, based on
the 2011 Spanish population census data.12 In Spain, color-
ectal cancer (CRC) is the most frequently diagnosed cancer
with a high incidence in the elderly.13,14 Therefore, we aimed
to study the association of socioeconomic inequalities with
overall mortality and survival among CRC patients in the
southern Spanish province of Granada, between 2011 and
2013.
Patients and Methods
Study Design, Participants, Data, and
Setting
We conducted a multilevel population-based cohort study.
The cohort was composed of all CRC cases identified
between the period 2011–2013, including all those patients
diagnosed during the same period and those who survived to
2011 from earlier cancer diagnosis in the southern Spanish
province of Granada.15 Data were drawn from the Granada
Cancer Registry, a population-based cancer registry in south-
ern Spain launched in 1985 and covering a population of
about 922,100 inhabitants.16 CRC corresponded to codes
C18-C21 of the International Classification of Diseases
10th revision (ICD-10).17 Patients’ follow-up started at the
date of their CRC diagnosis up to the end of the study on
December 31st, 2013. Patients who remained alive by the end
of the study were censored.
Variables
Outcome and Main Exposure
The study outcome was CRC patient’s vital status, and the
main exposure was patients’ socioeconomic status (SES)
referred to the year 2011. Patients’ SES was assessed by the
SDI at the census tract level, developed by the social deter-
minants of health working group of the Spanish Society of
Epidemiology.12 The SDI was created using data from the
Spanish 2011 census conducted by the Spanish National
Statistics Institute. The index includes information from six
indicators mainly related to employment and education:
percentage of manual workers (employed or unemployed),
percentage of occasional workers (employed or unem-
ployed), and percentage of the population with insufficient
education. We used the SDI as a proxy of patients’ SES. It
was measured as a standardized score (ie, mean: 0, standard
deviation: 1) with mean referred to the overall Spanish
population. We computed the quintiles (Q) of the SDI and
contrasted Q5 (most deprived) vs Q1 (less deprived) in
statistical analyses.12
Other variables
We included patient’s age, sex, and cancer stage at diag-
nosis in the analysis. Age at diagnosis was categorized into
five age groups. The stage at diagnosis variable was
defined as the combination of clinical and pathological
TNM stages at diagnosis, based on the 7th edition of the
TNM manual,18 and categorized into four groups.
The study was carried out in accordance with the
principles of the Declaration of Helsinki. The Granada
Cancer Registry complies with relevant national and
European data protection and privacy regulations. The
internal review board of the Andalusian School of Public
Health and the ethics committee from the Department of
Health of the Andalusian Regional Government approved
the study (PI18/01593). The data are held by the Regional
Government of Andalusia and the Andalusian Health
Department.
Statistical Analysis
We described the overall cohort of CRC patients using
counts and proportions and contrasted the differences in
sex, age, and cancer stage between the less (Q1) and most
deprived (Q5). We then computed the CRC mortality rates
per 1000 person-years, the unadjusted mortality rate ratios,
with 95% confidence intervals (CIs), and the tests for trend
p-values for all the variables.
We used a flexible parametric hazard modelling
approach consisting of restricted cubic spline-based hazard
models with three degrees of freedom and two internal
knots to derive unadjusted and adjusted excess mortality
(EM) risk and cancer-specific relative survival probabil-
ities by the quintiles of deprivation.19 We used as back-
ground mortality the information from the Spanish life
tables and performed a complete case analysis. We used
the scaled Schoenfeld residuals as a function of time in
order to evaluate the presence of a time-dependent effect
of the levels of deprivation and the rest of covariates.20
We fitted different models, including one variable at
each time, to control for confounding (ie, models 1–3).
The final model was adjusted for age, sex, and cancer
stage, including the interaction between time and cancer
stage (ie, fully adjusted model 4). From each model, we
derived the excess mortality risk ratios (EMRRs) and 95%
confidence intervals (CIs). To account for the clustering
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effect at the census tract level, we fitted a multilevel mixed-
effects hazard model. The model specification was the same
as model 4, but the patient’s census tract area of residence
was included as a random intercept.21 We plotted the
adjusted relative survival probabilities derived from model
4 for the levels of deprivation (Q5 vs Q1). We also com-
puted and plotted the standardized restricted mean survival
time for the most and less deprived CRC patients and its
difference in time (years).22,23 Then, we plotted the adjusted
relative survival probabilities by the quintiles of deprivation
(Q5 vs Q1) standardized to the empirical distribution of sex
and age at cancer diagnosis.24–26
In the sensitivity analysis, we assessed whether the SDI
2011 was correlated with the individual average of income
in euros by census tract for the calendar year 2015.27 We
explored the differences between patients who survived to
2011 from earlier cancer diagnosis with those diagnosed
between 2011 and 2013 and allowed for the delay entry of
those patients diagnosed before 2011 by setting the study
entry to the 01.01.2011. Finally, we explored different
modelling specifications, including the interaction between
the SDI and TNM stage, age, and sex.
We used Stata MP v.16.0 (StataCorp, College Station,
Texas, US), including the user-written programs stpm2
v.1.7.0, standsurv v.0.44 and stmixed v.2.0.328,29 for sta-
tistical analyses (Supplementary File 1).
Results
Among 3589 CRC patients and 12,148 person-years at
risk, 964 (26.9%) died before the end of 2013. After
a maximum follow-up time of 10-year, the overall mortal-
ity rate was 79.3 per 1000 person-years. Overall, 32% of
CRC patients were >75 years old, and 59% were male.
TNM cancer stages II and III were the most frequent, with
approximately one-third of the cases for each group. TNM
cancer stage was the only variable with missing informa-
tion (ie, 5%) (Table 1).
CRC mortality rates were higher among the most
deprived (Q5), males, those with advanced age (ie, >75
years), and patients with stage IV disease (ie, TNM stage
IV mortality rate: 332.5 per 1000 person-years). The most
deprived CRC patients (Q5) showed the highest mortality
rate compared with the other quintiles of deprivation (ie,
96.2 per 1000 person-years, 95% CI: 84.0–110.2) and four
times higher mortality rate than the less deprived (Q1) (ie,
mortality rate ratio: 1.4, 95% CI: 1.1–1.7). There was
evidence of an increased mortality risk across the levels
of the categories of age, cancer stage, and deprivation (ie,
test for trend p-value <0.001) (Table 2).
Supplementary Table 1 shows CRC vital status at 10
years, sex, age and TNM cancer stage at diagnosis by
deprivation (ie, Q1 and Q5 quintiles of deprivation).
There was no evidence of a difference in proportions of
sex and cancer stage by deprivation. However, most
deprived CRC patients were older (ie, Q5 and >75:
37.2% vs Q1 and >75: 28.5%) and showed a higher pro-
portion of mortality at 10 years (ie, Q5: 30.7% vs
Q1: 24.2%).
Overall, multivariate-adjusted models showed higher
EMRRs among the most deprived CRC patients compared
with the less deprived. After adjustment for sex, age, TNM
cancer stage at diagnosis, and accounting for patient’s area
of residence (ie, model 5) the most deprived CRC patients
showed a 60% higher EM compared with the less deprived
patients (ie, EM: 1.6, 95% CI: 1.1–2.3). The variability (ie,
variance) of CRC EM explained by the census tract was of
0.78 (95% CI: 055–1.11) (Table 3).
Figure 1A shows the standardized relative survival prob-
ability by quintiles of deprivation (Q5 vs Q1). The estimated
standardized relative survival probability at 10 years for the
less deprived group was 0.69 (95% CI: 0.66–0.73), and for
Table 1 Vital Status at 10 Years, Age, Sex, and TNM Cancer
Stage at Cancer Diagnosis Among Colorectal Cancer Patients in
Granada, Between 2011 and 2013, n = 3,589
Variables n (%)
Vital status at 10 years
Alive 2,617 (73.1)
Dead 964 (26.9)
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the most deprived was 0.63 (95% CI: 0.57–0.70). Figure 1B
shows the standardized mean survival times for the most and
the less deprived CRC patients, and Figure 1C the survival
gap in years as a function of time. The mean survival time at
ten years was 7.6 years (95% CI: 7.1–8.0) for the most
deprived CRC patients versus 8.0 years (95% CI: 7.8–8.2)
for the less deprived (Figure 1B). The survival gap increased
over time. At the end of the 10-year follow-up, the most
deprived CRC patients, on average, lived 0.43 years (158
days) less than the less deprived patients (mean survival
difference Q5 vs Q1: −0.43 years, 95% CI: [−0.78]–
[−0.08]) (Figure 1C).
Figure 2 shows the adjusted relative survival probabil-
ities for the most and less deprived CRC patients derived
from model 5 and marginalized over the categories of sex
and age. The most deprived patients showed lower survi-
val probabilities than the less deprived for any combina-
tion of age and sex. Compared with men, women showed
a smaller contribution to the survival gap between the
most and less deprived groups.
In the sensitivity analysis, we found a strong associa-
tion between the 2011 SDI and the average income per
person by census tract for the calendar year 2015 (ie,
Pearson correlation: −0.74, 95% CI: [−0.74]–[−0.73])
(Supplementary Figure 1).27 There was no evidence of
non-proportionality of the baseline hazard for the levels
of deprivation (ie, test for the scaled Schoenfeld residuals
p-value = 0. 706) (Supplementary Figure 2) and there was
no evidence of an interaction between deprivation with
age, sex, and TNM cancer stage (p-values 0.398, 0.480,
and 0.385, respectively). Furthermore, our results regard-
ing the association between deprivation and EM among
CRC were consistent with different models’ specifications
and allowing the delayed entry for those patients diag-
nosed before 2011 (ie, EMRR Q5 vs Q1: 1.3, 95% CI:
1.0–2.3). Supplementary Table 2 shows the differences in
the distribution of deprivation, age, sex, and TNM cancer
stage among CRC patients who survived to 2011 from
earlier cancer diagnosis with those diagnosed between
2011 and 2013. Both groups showed a similar distribution
in the variables under study. Furthermore, in stratified
sensitivity analysis assessing the consistency of the EM
risk comparing the quintiles of deprivation Q5 vs Q1 for
both groups, showed similar results (ie, EMRR = 1.4; 95%
Table 2 Ten-Year Overall Mortality Rate and Mortality Rate Ratios by Sociodemographic Characteristics, TNM Cancer Stage at
Diagnosis, and Quintiles of Deprivation Among Colorectal Cancer Patients in Granada, Between 2011 and 2013, n = 3,589
Variables Deaths/Pyr Mortality Rate per 1000 pyr (95% CI) Mortality Rate Ratio (95% CI) p-value
Sex <0.001
Male 602/6,878 87.5 (80.8–94.8) Ref.
Female 362/5,270 68.7 (62.0–76.1) 0.8 (0.7–0.9)
Age at diagnosis, years <0.001*
<50 40/1,024 39.1 (28.7–53.3) Ref.
50–59 74/1,997 37.0 (29.5–46.5) 0.9 (0.6–1.4)
60–69 163/3,609 45.2 (38.7–52.7) 1.2 (0.8–1.6)
70–75 186/2,631 70.7 (61.2–81.6) 1.8 (1.3–2.5)
>75 501/2,886 173.6 (159.0–189.5) 4.4 (3.2–6.1)
TNM stage at diagnosis <0.001*
I 96/2,529 38.0 (31.1–46.4) Ref.
II 215/4,215 51.0 (44.6–58.3) 1.3 (1.1–1.7)
III 238/3,867 61.5 (54.2–69.9) 1.6 (1.3–2.1)
IV 331/995 332.7 (298.6–370.3) 8.6 (7.0–11.0)
Quintiles of deprivation <0.001*
Q1 (less deprived) 178/2,569 69.3 (59.8–80.2) Ref.
Q2 175/2,484 70.5 (60.7–81.7) 1.0 (0.8–1.2)
Q3 198/2,458 80.6 (70.1–92.6) 1.2 (0.9–1.4)
Q4 204/2,465 82.8 (72.1–94.9) 1.2 (1.0–1.5)
Q5 (most deprived) 209/2,172 96.2 (84.0–110.2) 1.4 (1.1–1.7)
Note: *Test for trend p-value.
Abbreviations: pyr, person-years; CI, confidence interval.
Luque-Fernandez et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Clinical Epidemiology 2020:12800
CI: 0.8–2.3 among CRC patients who survived to 2011
from earlier cancer diagnosis, and EMRR = 1.3; 95% CI:
1.0–1.9 among those CRC patients diagnosed between
2011 and 2013).
Discussion
We found a consistent association between deprivation and
CRC EM in Granada, southern Spain. Most deprived CRC
patients showed a higher EM than less deprived patients.
At the end of the 10-year follow-up, the most deprived
CRC patients, on average, lived 158 days less than the less
deprived ones.
Our results are in line with others in the European
context, where several studies assessed CRC survival
based on SES.30–43 In this regard, Fowler et al39 conducted
a study in England concluding that 90-day probability of
death rose with increasing deprivation. Accordingly, in
West Scotland, deprivation was independently associated
with poorer 5-year CRC excess hazard (HR: 1.25, 95% CI:
1.03–1.51, p-value: 0.024);30 and in the Northern Region of
England, deprivation was a predictor of overall survival in
patients with CRC.31 In Switzerland, Feller et al34 observed
a social gradient for later-stage CRC with adjusted odds
ratios of 1.11 (95% CI: 0.97–1.19) and 1.28 (95% CI: 1.-
08–1.50) for middle and low socioeconomic position com-
pared to high socioeconomic position, respectively.
Survival was lower in patients with CRC with a low socio-
economic position in the unadjusted model (HR: 1.18, 95%
CI: 1.07–1.30). Moreover, CRC survival by SES was
explored in the Swedish Rectal Cancer Registry,41 and
their results evidenced that income was of particular impor-
tance in stage III disease. Other epidemiological studies
showed socioeconomic association with CRC screening32
and CRC risk.44 Therefore, socioeconomic inequalities are
independently related to cancer mortality45 and have
a strong impact on survival.46
Table 3 Excess Mortality Risk by Deprivation Quintiles Adjusted for Sex, Age, TNM Cancer Stage at Diagnosis, and Census Tract












Q1 Ref. Ref. Ref. Ref. Ref.
Q2 1.0 (0.7–1.4) 1.0 (0.7–1.4) 0.9 (0.7–1.3) 0.8 (0.8–1.5) 1.2 (0.8–1.8)
Q3 1.2 (0.9–1.7) 1.2 (0.9–1.7) 1.2 (0.9–1.6) 1.4 (1.0–1.8) 1.5 (1.0–2.1)
Q4 1.1 (0.8–1.6) 1.2 (0.8–1.5) 1.1 (0.8–1.6) 1.3 (0.9–1.7) 1.4 (1.0–2.0)
Q5 1.6 (1.2–2.1) 1.6 (1.2–2.1) 1.4 (1.1–1.9) 1.5 (1.1–2.0) 1.6 (1.1–2.3)
Sex
Female Ref. Ref. Ref. Ref.
Male 1.2 (1.0–1.4) 1.2 (1.0–1.4) 1.1 (0.9–1.4) 1.2 (1.0–1.5)
Age at diagnosis
<50 Ref. Ref. Ref.
50–59 0.8 (0.5–1.3) 1.1 (0.7–1.7) 1.2 (0.7–1.8)
60–69 0.9 (0.6–1.3) 1.0 (0.7–1.5) 1.2 (0.7–1.8)
70–75 1.1 (0.7–3.6) 1.4 (0.8–2.0) 1.5 (0.9–2.3)
>75 2.5 (1.8–3.6) 3.1 (2.1–4.4) 4.0 (2.7–6.1)
TNM stage at diagnosis
I Ref. Ref.
II 2.8 (1.1–7.1) 2.4 (1.0–6.0)
III 4.5 (1.7–11.60) 4.4 (1.8–10.4)
IV 32.7 (13.5–79.7) 44.7 (18.9–105.9)
Census tracts
Variance (95% CI) 0.78 (0.55, 1.11)
Notes: Model 1: univariate excess mortality by quintiles of deprivation. Model 2: bivariate excess mortality by deprivation adjusted for sex. Model 3: multivariate excess
mortality by deprivation adjusted for sex and age at diagnosis in categories. Model 4: multivariate excess mortality by deprivation adjusted for sex, age and cancer TNM
stage. Model 5: multilevel multivariate excess mortality by deprivation adjusted for sex, age and cancer TNM stage accounting for the census tract level area.
Abbreviations: EMRR, excess mortality risk ratio; CI, confidence interval.
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There is evidence showing difficulties in accessing
CRC screening among the most deprived patients.32 This
has been shown to increase the probability of late cancer
diagnosis (stage IV) or lower the probability of early
cancer detection (stage I) among the most deprived CRC
patients.47 However, our study showed no evidence of an
association between TNM stage and deprivation. We argue
that the absence of CRC screening in the province of
Granada might have affected the survival gap that we
found between the most and less deprived groups.
However, several studies analysing the impact of SES in
the participation of the screening programs found contro-
versial results supporting the need for further evidence.48–
50 Despite the absence of screening in the province of
Granada, the reasons behind these inequalities need further
investigation in order to improve equality outcomes in all
social groups.
In our study, we also found that women showed
a smaller contribution to the survival gap between the
most and less deprived groups. It aligns with the results
of Antunes et al37 in Portugal where they found a pattern
of worse 5- and 10-year net survival among male patients
in the most deprived groups (survival gap between the
most and least deprived groups: −5% both at 5 and 10
years) but not such a clear pattern in female patients. It
might be due to sex differences lifestyles such as drinking,
smoking, and other cancer-related risk factors.
Furthermore, we found the highest 10-year EM and
survival gap among older male patients (>75 years). We
argue that among older CRC male patients, socioeconomic
inequalities can interact with other factors related to treat-
ment decision-making (eg, health literacy, comorbidities,
functional status, and social support).51,52 For instance, the
marital status may play an essential role in cancer-survival
Deprivation quintiles:
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Figure 1 Relative survival probability, restricted mean survival time, and restricted mean survival time differences in years by levels of deprivation (Q5 vs Q1) among
colorectal cancer patients in Granada, between 2011–2013, n = 3582.
Notes: (A) Relative survival probability by the quintiles of deprivation. Solid line: Q5 and dashed line: Q1. (B) Restricted mean survival time in years by the quintiles of
deprivation. Solid line: Q5 and dashed line: Q1. (C) Restricted mean survival time differences in years by the quintiles of deprivation (Q5 vs Q1). Solid line: differences, grey
shaded area: 95% CI.
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among older men as single compared to married people
have elevated odds of being diagnosed at later stages34 and
also have an increased risk of CRC death.41,53
The SDI is limited, as it did not include information
regarding the average income by census tracts. It is mainly
an index reflecting levels of deprivation by education and
employment. However, in sensitivity analysis, we found
a strong correlation between the SDI 2011 and the average
income by census tract for the year 2015. Furthermore, the
SDI is an ecological variable that we used as a proxy for
individual SES status. Classically, SES in population-
based cancer research has been measured at an ecological
level. However, it has led to mild associations between
SES and cancer survival outcomes, mainly due to the
ecological fallacy.54 This measurement bias might have
affected the strength of the association we found towards
the null, and further studies could try to include individual
SES information. Our analytical approach partially
addressed this issue, reducing modelling overdispersion
due to the inclusion of the census tracts as a random
intercept in the model. However, to compute the EM we
used life tables stratified by age and sex, but not by
deprivation, and it might have introduced some bias.
Nevertheless, in sensitivity analysis results contrasting
the overall and the relative setting did not show strong
differences suggesting a homogeneous effect of depriva-
tion on overall and cancer-specific mortality by depriva-
tion. In order to assess the direction and the amount of this
bias, further studies using life tables stratified by depriva-
tion are needed in Spain.
Other limitations are related to the setting of time. All the
analysis variables were referred at baseline (ie, the time of
cancer diagnosis), including the quintiles of deprivation
(exposure) for all cancer patients diagnosed between 2011
and 2013. However, for CRC patients who survived to 2011
from early cancer diagnosis, deprivation was not assessed at
their cancer diagnosis. Thus, in sensitivity analysis allowing
for the delayed entry to the 01.01.2011, we showed consis-
tent results for the association between deprivation and EM.



























































































































































































































































Figure 2 Sex-specific relative survival probability by deprivation (Q5 vs Q1) and age at cancer diagnosis among colorectal cancer patients in Granada, between 2011–2013,
n = 3,582.
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proportion of TNM stage IV at diagnosis than CRC cases
diagnosed between 2011 and 2013. However, in the stratified
analysis, we show that the association between deprivation
and EM remained consistent. Finally, our study is limited to
only one Spanish province, but more studies are needed to
generalize our results to the rest of the country.
In conclusion, there is a consistent survival gap between
the most and less deprived CRC patients in Granada, south-
ern Spain, characterized by a higher EM due to cancer in the
most deprived group. These differences were more pro-
nounced in males than females, patients with advanced
age, and patients diagnosed with stage IV. Public health
policies and preventive strategies are needed to reduce
socioeconomic inequalities and the observed survival gap
between the most and less deprived CRC patients in
Granada, southern Spain.
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